Marble Harbor Investment Counsel LLC Has $5.75 Million Holdings in Stericycle, Inc. (NASDAQ:SRCL)

Marble Harbor Investment Counsel LLC cut its stake in shares of Stericycle, Inc. (NASDAQ:SRCL) by 2.1% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 98,962 shares of the business services provider’s stock after selling 2,100 shares during the quarter. Marble Harbor Investment Counsel LLC owned approximately 0.11% of Stericycle worth $5,753,000 at the end of the most recent quarter.

A number of other large investors have also bought and sold shares of SRCL. Vanguard Group Inc. grew its position in Stericycle by 0.6% in the 4th quarter. Vanguard Group Inc. now owns 8,969,118 shares of the business services provider’s stock valued at $444,509,000 after purchasing an additional 52,576 shares during the period. Capital Research Global Investors raised its holdings in shares of Stericycle by 11.4% in the 1st quarter. Capital Research Global Investors now owns 6,667,911 shares of the business services provider’s stock worth $351,732,000 after acquiring an additional 679,974 shares during the last quarter. Earnest Partners LLC lifted its position in Stericycle by 12.4% in the 1st quarter. Earnest Partners LLC now owns 2,460,020 shares of the business services provider’s stock valued at $129,766,000 after acquiring an additional 271,025 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in Stericycle by 10.8% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,971,719 shares of the business services provider’s stock valued at $97,720,000 after purchasing an additional 192,045 shares during the last quarter. Finally, Schroder Investment Management Group increased its holdings in Stericycle by 8.1% during the 4th quarter. Schroder Investment Management Group now owns 1,739,644 shares of the business services provider’s stock worth $86,217,000 after purchasing an additional 129,822 shares in the last quarter. 98.82% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on the company. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $62.00 target price (down previously from $69.00) on shares of Stericycle in a research report on Tuesday, June 4th. Truist Financial upped their price objective on shares of Stericycle from $50.00 to $62.00 and gave the stock a “hold” rating in a research report on Tuesday, June 4th. StockNews.com started coverage on Stericycle in a research report on Monday, September 9th. They set a “hold” rating for the company. Finally, Keefe, Bruyette & Woods boosted their price target on shares of Stericycle from $135.00 to $142.00 and gave the stock an “outperform” rating in a report on Tuesday, June 4th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, Stericycle has an average rating of “Hold” and a consensus target price of $74.00.

Stericycle Stock Performance

NASDAQ:SRCL opened at $61.71 on Monday. Stericycle, Inc. has a 1-year low of $37.78 and a 1-year high of $61.77. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.13 and a quick ratio of 1.13. The business has a 50 day moving average of $59.00 and a 200 day moving average of $54.57. The company has a market capitalization of $5.73 billion, a price-to-earnings ratio of -280.50, a PEG ratio of 3.37 and a beta of 1.11.

Stericycle (NASDAQ:SRCL) last released its earnings results on Thursday, July 25th. The business services provider reported $0.61 EPS for the quarter, beating the consensus estimate of $0.57 by $0.04. Stericycle had a net margin of 1.37% and a return on equity of 7.94%. The company had revenue of $661.60 million for the quarter, compared to analyst estimates of $672.07 million. On average, sell-side analysts predict that Stericycle, Inc. will post 2.29 earnings per share for the current fiscal year.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.